Pure Global

TRIP-patch vs Duplex - Trial NCT06402097

Access comprehensive clinical trial information for NCT06402097 through Pure Global AI's free database. This phase not specified trial is sponsored by St. Antonius Hospital and is currently Completed. The study focuses on Erectile Dysfunction. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06402097
Completed
Trial Details
ClinicalTrials.gov • NCT06402097
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
TRIP-patch vs Duplex
'Transdermal Rigidity Assessment Via Ischemia of the Penis (TRIP). A New Sensor-driven Device to Measure Maximal Rigidity.'

Study Focus

Erectile Dysfunction

Observational

Sponsor & Location

St. Antonius Hospital

Nieuwegein, Netherlands

Timeline & Enrollment

N/A

Jun 05, 2020

Sep 25, 2020

20 participants

Primary Outcome

change in sensor-readings

Summary

To measure saturation and desaturation of the cavernosal tissue with a cutaneous placed
 penile sensor, before and during full rigidity. To validate discriminating sensor-readings
 between flaccid state and full rigidity of the penis

ICD-10 Classifications

Orgasmic dysfunction
Other disorders of penis
Other specified disorders of penis
Sexual dysfunction, not caused by organic disorder or disease
Testicular dysfunction

Data Source

ClinicalTrials.gov

NCT06402097

Non-Device Trial